Cargando…

Human phase I metabolism of the novel synthetic cannabinoid 5F-CUMYL-PEGACLONE

PURPOSE: 5F-CUMYL-PEGACLONE is a recently emerged γ-carbolinone derived synthetic cannabinoid. The present study aimed to identify phase I metabolites to reliably prove consumption of the substance by urine analysis and to differentiate from the uptake of the non-fluorinated analog CUMYL-PEGACLONE....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mogler, Lukas, Halter, Sebastian, Wilde, Maurice, Franz, Florian, Auwärter, Volker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315001/ https://www.ncbi.nlm.nih.gov/pubmed/30636984 http://dx.doi.org/10.1007/s11419-018-0447-4

Ejemplares similares

5F-Cumyl-PINACA in ‘e-liquids’ for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA
por: Angerer, Verena, et al.
Publicado: (2018)

In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA
por: Kevin, Richard C., et al.
Publicado: (2017)

Phase I In Vitro Metabolic Profiling of the Synthetic Cannabinoid Receptor Agonists CUMYL-THPINACA and ADAMANTYL-THPINACA
por: Monti, Manuela Carla, et al.
Publicado: (2021)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022)

Detection of AP‐237 and synthetic cannabinoids on an infused letter sent to a German prisoner
por: Giorgetti, Arianna, et al.
Publicado: (2022)

Editorial: Toxicological profiles and pharmacological properties of synthetic cannabinoids: From chemical and analytical issues to fatal and non-fatal intoxications
por: Giorgetti, Arianna, et al.
Publicado: (2023)

Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists
por: Giorgetti, Arianna, et al.
Publicado: (2020)

Finding cannabinoids in hair does not prove cannabis consumption
por: Moosmann, Bjoern, et al.
Publicado: (2015)

Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4
por: Ferk, Franziska, et al.
Publicado: (2016)

Synthetic cannabinoids
por: Bilici, Rabia
Publicado: (2014)

“Spice”-related deaths in and around Munich, Germany: A retrospective look at the role of synthetic cannabinoid receptor agonists in our post-mortem cases over a seven-year period (2014–2020)
por: Groth, Olwen, et al.
Publicado: (2023)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
por: Brents, Lisa K., et al.
Publicado: (2011)

Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models
por: Dahm, Patrick, et al.
Publicado: (2021)

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
por: Theunissen, Eef L., et al.
Publicado: (2021)

Metabolic Pathways and Potencies of New Fentanyl Analogs
por: Wilde, Maurice, et al.
Publicado: (2019)

Effectiveness of the synthetic cannabinoids seminar
por: Seyit, Murat, et al.
Publicado: (2016)

Synthetic cannabinoids and renal injury
por: Alp, Alper
Publicado: (2015)

A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues
por: Giorgetti, Arianna, et al.
Publicado: (2021)

A new highly active La(2)O(3)–CuO–MgO catalyst for the synthesis of cumyl peroxide by catalytic oxidation
por: Liu, HanShuang, et al.
Publicado: (2021)

Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice
por: Willecke, Florian, et al.
Publicado: (2011)

Characterization of the synthetic cannabinoid MDMB-CHMCZCA
por: Weber, Carina, et al.
Publicado: (2016)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Broadly Neutralizing Synthetic Cannabinoid Vaccines
por: Lin, Mingliang, et al.
Publicado: (2020)

Synthetic Cannabinoids: An Emerging Cause of Coagulopathy
por: Ullah, Shakir, et al.
Publicado: (2020)

Heroin Adulterated with the Novel Synthetic Cannabinoid, 5F-MDMB-PINACA: A Case Series
por: Ershad, Muhammed, et al.
Publicado: (2020)

The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
por: Orsini, Jose, et al.
Publicado: (2015)

Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
por: Kokona, Despina, et al.
Publicado: (2016)

Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion
por: Adedinsewo, Demilade A., et al.
Publicado: (2016)

Review of the many faces of synthetic cannabinoid toxicities
por: Alipour, Azita, et al.
Publicado: (2019)

DTI-MRI findings in synthetic cannabinoid users
por: GÖKHARMAN, Dilek, et al.
Publicado: (2020)

Critical Illness Secondary to Synthetic Cannabinoid Ingestion
por: Kourouni, Ismini, et al.
Publicado: (2020)

Might synthetic cannabinoids influence neural differentiation?
por: Bekman, Evguenia, et al.
Publicado: (2021)

Persistent Coagulopathy After Synthetic Cannabinoid Use
por: Haider, Mahvish, et al.
Publicado: (2023)

Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation
por: Zawatsky, Charles N., et al.
Publicado: (2020)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist
por: Burstein, Sumner H, et al.
Publicado: (2013)

The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
por: Cohen, Koby, et al.
Publicado: (2018)

QSAR Model for Predicting the Cannabinoid Receptor 1 Binding Affinity and Dependence Potential of Synthetic Cannabinoids
por: Lee, Wonyoung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bqieuj1gls44gfl4b47ro1f27g